NRx Pharmaceuticals (NRXP) Reports In-Line Q1 EPS

NRx Pharmaceuticals (NASDAQ: NRXP) reported Q1 EPS of $0.00. Revenue for the quarter came in at $1.07 million.

For earnings history and earnings-related data on NRx Pharmaceuticals (NRXP) click here.

You May Also Be Interested In

• Worthington Steel, Inc. (WS) Misses Q4 EPS by 3c
• BAE Systems Plc (BA:LN) (BAESY) New Top Pick in EU Defence at Morgan Stanley
• SuperX AI holds talks with Kazakhstan on proposed 1GW computing park